University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
NCT Number: NCT07724041
The goal of this pilot, feasibility study is to evaluate the feasibility and preliminary impact of a finance-specific psycho-oncology intervention, as well as to explore perceptions of and experiences with this financial psycho-oncology intervention for patients with cancer experiencing financial hardship. The main questions it aims to answer are:
1. Is this financial psycho-oncology intervention feasible, acceptable, and appropriate for patients with cancer experiencing financial hardship? 2. How can we refine the financial psycho-oncology intervention to best address financial distress for patients with cancer experiencing financial hardship?
Patients enrolled in the intervention will receive 2, 60-minute long, finance-specific psycho-oncology sessions per month over the course of 3 months, for a total of 6 sessions over the course of the intervention. Patients will complete surveys during intervention enrollment and after intervention completion to assess secondary outcomes of financial hardship, psychological distress, stress, and anxiety. Individuals who consent to the financial psycho-oncology intervention will also be invited to participate in a 30-minute semi-structured interview to explore their perceptions of and experiences with the financial psycho-oncology intervention, including concepts of participation and engagement, relevance and acceptability, content and understanding, logistics and practicality, and potential impact.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Birmingham, Alabama, 35233, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Program which integrates emotional support, coping strategies, and financial psychoeducation to enhance patients' capacity to cope with both their emotional and financial burdens due to cancer.
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
50% of contacted patients consenting to participate
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
70% of consenting patients completing the program per protocol
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
<15% missing survey data
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
as measured by COmprehensive Score for financial Toxicity (COST)
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
as measured by National Comprehensive Cancer Network Distress Thermometer and Problem List
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
as measured by Perceived Stress Scale (PSS-10)
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
as measured by PROMIS Emotional Distress - Anxiety - Short Form 4
Time frame: From enrollment to the end of the financial psycho-oncology intervention at 3 months
as measured by PROMIS Emotional Distress - Depression - Short Form 4
Contact information is provided by the study sponsor or research team.
University of Alabama at Birmingham
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06430840
Behavior, Behavioral Symptoms
Costa Mesa, California, United States
View Trial DetailsNCT06611982
Behavior, Behavioral Symptoms
Philadelphia, New York, United States
View Trial DetailsNCT07729696
Anxiety, Anxiety Disorders
Denpasar, Bali, Indonesia
View Trial DetailsNCT07664436
Behavior, Behavioral Symptoms
New York, United States
View Trial Details